Allergan (AGN) Declares $0.74 Quarterly Dividend; 1.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
After-Hours Movers 03/17: (TGE) (HOLX) (AGN) Higher; (MDB) (CHK) (FDX) Lower (more...)
March 17, 2020 5:54 PM EDTAfter-Hours Movers
Tallgrass (NYSE: TGE) 10.1% HIGHER; Blackstone (NYSE: BX) Still Scheduled to Close Tallgrass (NYSE: TGE) Deal With No Material Changes- Bloomberg, Citing DealReporter
AbbVie (ABBV), Allergan (AGN) Sign Consent Decree Agreement with FTC Staff on Pending Transaction
March 17, 2020 4:31 PM EDTAbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that they have entered into a consent decree agreement with staff of the U.S. Federal Trade Commission... More



